Target Cancer Therapy Inc. (TCTI) is a company committed to developing new generation cancer treatment to improve the quality of life for cancer patients. Cooperating with numerous renowned cancer research institutions, including Memorial Sloan-Kettering Center (New York), Duke University Medical Center, and the National Institute of Health, TCTI develops a technology that uses focused heat energy to control gene therapy, thus directly targeting the tumour cells . The company already received necessary official approvals to enter the next stage in developing its technology. With expanded operation into the market in China, TCTI aims to ultimately deliver a product that will revolutionize cancer treatment around the world.
|
